Where does Boston Medical Center Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Boston Medical Center Corporation ranks #7,531 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Boston Medical Center Corporation hold?

Boston Medical Center Corporation holds 43 US utility patents granted between 2015 and 2025, spanning 28 technology areas.

What is Boston Medical Center Corporation's Innovation Score?

Boston Medical Center Corporation has an Innovation Score of 46.4 out of 100 (top 21% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Boston Medical Center Corporation focus on?

Boston Medical Center Corporation's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 25 patents, ranking #906 of 7,163 assignees active in that subclass. Grants appear in 28 CPC subclasses total.

Is Boston Medical Center Corporation's patent grant rate increasing or decreasing?

Boston Medical Center Corporation's recent grant velocity is +16% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Boston Medical Center Corporation's patents?

Boston Medical Center Corporation's patents average 16.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Boston Medical Center Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Boston Medical Center Corporation

USPTO PatentsView assignee record - 43 granted patents across 28 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Boston ranks #7,531 of 49,997 tracked US assignees by granted-patent volume, with 43 patents across 28 technology areas.

#7,531
of 49,997 US assignees by volume: Top 21%
by Innovation Score (46.4/100): 16.6
avg claims per patent: +16%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7531 · US Corporation #7,531 · 43 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 43 grants
UPPER-Q #7,531/49,997
PHOTO-FINISH Balenciaga
CPC-FOCUS A61K · 28 areas
INNOV-PAR 46.4/100
CLAIMS-RICH 16.6 claims/avg
TYPE-USCORP US Corporation
VEL-UP +16% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Balenciaga (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Boston’s 46.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.1 pts (28%) Velocity 4.7 pts (10%) Breadth 18.7 pts (40%) Claim depth 9.9 pts (21%)

Qualcomm Incorporated · highest

85
Boston Medical Center · this assignee

46
Hanwha Chemical · near

46
National Jewish Health · near

46
Nippon Chemi-Con · near

46
Red Hat Israel · near

46
3D Lighting… · lowest

7

What this shows Boston's Innovation Score is 46.4/100 (top 21% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Boston?

Each dot is one of Boston’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Boston’s own 16.6 claims/patent is at or below the 18.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Boston vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Boston's grants concentrate

Boston Medical Center Corporation is a focused PatentsView assignee: 28 CPC subclasses with 58.1% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2019 (7 grants) versus a trough of 1 in 2023. By volume, Boston sits between Barnes & Noble College Booksellers, LLC and Bracco Suisse SA.

Boston's three-year grant acceleration

Boston Medical Center Corporation shows 12 grants in 2022–2024 against only 17 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Barnes & Noble Co…

43
BHS Corrugated Ma…

43
Blue Goji

43
Bongiovi Acoustic

43
Balenciaga

43
Bank of Montreal

43
Bioatla

43
Bracco Suisse

43
Boston Medical Ce… ◀

43

What this shows Boston holds 43 patents at rank #7,529, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Boston

By rank, the assignees closest to #7,529 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Boston's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Boston, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Boston ranks #906 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (46 here).

National Jewish Health 46 Hanwha Chemical Corporation 46 Nippon Chemi-Con Corporation 46 Red Hat Israel Ltd. 46

Boston's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 21% higher than 79% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Boston Medical Center Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	7.0%
2017	4	9.3%
2018	5	11.6%
2019	7	16.3%
2020	6	14.0%
2021	4	9.3%
2022	7	16.3%
2023	1	2.3%
2024	4	9.3%
2025partial year	2	4.7%

Which technologies does Boston Medical Center Corporation patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 25

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 23

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 19

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 18

C07K - Peptides 16

A61B - DIAGNOSIS; SURGERY; Identification 8

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 5

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 4

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 4

C12Y - Enzymes 3

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 3

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

C07D - Heterocyclic Compounds 2

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 2

Top 15 of 28 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Boston Medical Center Corporation's patent record in context - here's where to go next.

Boston Medical Center Corporation's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 58.1% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #7,531 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Boston Medical Center Corporation against Barnes & Noble College Booksellers, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 46.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.